HIRA

정신질환자 지속치료 지원 시범사업 평가 연구

  • 879
  • 407
Metadata Downloads
Type
Research report
Author(s)
백종우박선영박영주석정호이두웅임정숙정선재김혜교
Issued Date
2023-02
Keyword
정신질환자지속치료지원수가시범사업
Publisher
건강보험심사평가원
URI
https://repository.hira.or.kr/handle/2019.oak/3110
Table Of Contents
요약 ···························································································· ⅰ

제1장 서론 1
1. 연구의 필요성 및 목적 ············································································ 3
가. 연구의 필요성 ···························································································· 3
나. 연구의 목적 및 목표 ··················································································· 7
2. 연구내용 및 방법 ··················································································· 8
가. 연구내용 ···································································································· 8
나. 연구방법 ···································································································· 9
3. 연구추진 체계 ······················································································ 10

제2장 선행연구 고찰 11
1. 정신질환자 지속치료의 필요성 ······························································ 13
2. 해외사례 ···························································································· 15
가. 일본 ········································································································ 15
나. 대만 ········································································································ 19

제3장 정신질환자 지속치료 지원 시범사업 효과성 평가 21
1. 개요 ···································································································· 23
가. 조사 대상 ································································································ 23
2. 분석결과 ······························································································ 28
가. 시범사업 청구현황 ···················································································· 28
나. 정신질환자 지속치료 지원 시범사업 효과 분석 [1:5 matched panel] ··········· 36
3. 세부사업별 연계성 ················································································ 86
가. 세부사업별 참여 대상자 ············································································· 86
나. 세부사업별 연계율 ···················································································· 87
4. 소결 ···································································································· 88

제4장 시범사업 참여기관 및 전문가 조사 89
1. 시범사업 참여기관 조사 ······································································· 91
가. 조사 개요 ······························································································ 91
나. 조사 결과 ································································································ 93
2. 전문가 자문 ······················································································· 125
3. 소결 및 제언 ····················································································· 140

제5장 정신질환자 지속치료 지원 시범사업 수가체계 149
1. 정신질환자 지속치료 지원 시범사업 수가 추산 ····································· 151
가. 응급입원, 급성기 입원 관련 예상 수익 ···················································· 151
나. 병원기반 사례관리 예상 수익 ································································· 154
다. 낮병동 예상 수익 ·················································································· 155
2. 상급종합병원 급여진료비 분석 ······························································ 156
가. 2021년 기준 상급종합병원 정신건강의학과 입원일당 진료비 ····················· 156
3. 소결 및 제언 ···················································································· 157

제6장 결론 및 제언 160
1. 정신질환자 지속치료 지원 시범사업의 의의 및 연구 개요 ····················· 161
가. 시범사업의 의의 ···················································································· 161
나. 본 연구의 개요 ····················································································· 161
2. 정신질환자 지속치료 지원 시범사업의 효과성과 한계 ·························· 162
가. 문제의 크기에 비해 낮은 급성기 치료 활성화 시범사업 수가인상 효과 ······· 162
나. 병원기반 사례관리 시범사업 활성화의 어려움 ··········································· 163
다. 낮병동 관리료 시범사업 ········································································· 163
라. 환자와 의료진의 안전문제 ······································································ 164
마. 정신의료전달체계와 정신질환자 지속치료 지원 시범사업 ···························· 164
3. 정신질환자 지속치료 지원 시범사업의 현황과 개선방향 ························· 165
가. 사업수행체계 개선 ·················································································· 165
나. 현행 수가체계 및 수가 개선 ···································································· 166
다. 전문인력 확보를 위한 노력 ······································································ 167
라. 치료 적용에서의 효과성 개선안 ······························································ 169
마. 시범사업 수행을 위한 시스템 마련 ··························································· 169
4. 활용방안 ·························································································· 170
가. 정신질환자 지속치료 지원 시범사업과 정신의료체계 ·································· 170
나. 향후 시범사업 효과성 평가 연구 ···························································· 171

◾ 참고 문헌 ···················································································· 172
Publisher
건강보험심사평가원
Location
KOR
Citation
백종우. (2023-02). 정신질환자 지속치료 지원 시범사업 평가 연구.
Appears in Collections:
HIRA 연구 > 2. 위탁연구
공개 및 라이선스
  • 공개 구분공개
파일 목록

열람하신 정보에 대해 만족하십니까?

기타의견

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.